MAXIMIZING POSITIVE SYNERGIES - World Health Organization

PEPFAR*
Year Amount Disbursed (in US$)
2004 20,770,000
2005 26,610,000
2006 29,585,000
2007 29,935,000
2008 29,829,900
TOTAL: 136,729,900
*Not a PEPFAR focus country; above sums represent total allocations to PEPFAR
country programmes from bilateral U.S. sources including USAID, Department of
Health and Human Services, Department of Labor, and Department of Defense.
GAVI (in US$)
Disease Priority Amount Approved (in US$)
Hepatitis B vaccine 66,163,000
Vaccine introduction grant 1,200,000
Injection Safety 25,929,319
TOTAL: 93,292,319
Disease specific programmes have a long history in India, with the central government targeting
specific conditions since the 1950’s. Currently around ten such programmes are operational,
covering a variety of diseases. They operate through the government funded public health system.
In a weak health system environment and where funds for the health sector are limited, it becomes
important to understand how such disease control programmes can contribute to strengthening
health systems.
Several GHIs operate in India, including Global Fund, PEPFAR and GAVI (Tables 1-3). The Global
Fund came to India in 2003 and has rapidly become one of the largest external donors to India’s
health sector. India has received support from various Global Funds rounds for three of its national
disease control programmes: the National AIDS Control Programme (NACP - 2 and 3), the Revised
National TB Control Programme (RNTCP) and National Vector Borne Disease Control Program for
malaria. For HIV/AIDS there have been three Principal Recipients through Round Six of Global Fund
funding: the National AIDS Control Organization (NACO) [7], the Population Foundation of India
(PFI) and the India HIV/AIDS Alliance. The last two Principal Recipients are CSOs. In Round Seven
there were two other Principal Recipients, the Indian Nursing Council and the Tata Institute of
Social Sciences. For TB, the Central TB Division in the Ministry of Health and Family Welfare has
been the only Principal Recipient in all funding rounds. Contributions by Global Fund and other
donors to the NACP-3 and RNTCP are substantial. However, HIV/AIDS has received the bulk of
Global Fund support to India. Around 45% of the NACP-3’s budget is from external sources [8] of
which approximately half comes from the Global Fund. Overall, the Global Fund contributes 26%
of the NACP-3 budget, a substantial increase from 6% for the NACP-2 [9].
90